从产业发展角度看美国FDA明智监管理念对我国的启示

The enlightenment of FDA smart regulatory philosophy to China seen from the perspective of industrial development

基于文献研究,分析美国FDA明智监管理念的特征与作用,探讨其对医药产业发展的促进作用,为我国药品监管的提供启示。我国可以通过不断推进监管科学、重视政府信息公开、拓宽资金来源渠道等监管手段,在保障公众健康的基础上,实现促进医药产业发展的目标。

Based on the literature search, the characteristic and effect of FDA smart regulatory philosophy were analyzed, and the promoting effect of this philosophy on the development of pharmaceutical industry was discussed so as to provide enlightenment for the drug regulation of China. The goal of promoting the development of the pharmaceutical industry in China may be achieved on the basis of the protection of public health by some regulatory measures such as constantly advancing the regulatory science, paying great attention to the disclosure of government information and broadening the channels of funding sources.